Percutaneous coronary intervention in Brazil. Results from the Brazilian Public Health System

Arquivos Brasileiros de Cardiologia

Volumn 96, Issue 4, 2011, Pages 317-324

  Piegas, Leopoldo Soares ^a   Haddad, Nagib ^a  

^a INSTITUTO DANTE PAZZANESE DE CARDIOLOGIA   (Brazil)

Author keywords

Angina pectoris; Angioplasty transluminal percutaneous coronary; Single Health System

Indexed keywords

ACUTE HEART INFARCTION; ADOLESCENT; ADULT; AGED; ANGINA PECTORIS; BRAZIL; CHILD; CORONARY ARTERY DISEASE; CORONARY STENT; DATA ANALYSIS; FEMALE; GEOGRAPHIC DISTRIBUTION; HEALTH CARE SYSTEM; HOSPITAL BED CAPACITY; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEWBORN; PERCUTANEOUS CORONARY INTERVENTION; REVIEW; SEX DIFFERENCE; TREATMENT PLANNING;

ADOLESCENT; AGE DISTRIBUTION; AGED; ANGIOPLASTY, BALLOON, CORONARY; BRAZIL; CHILD; CHILD, PRESCHOOL; CORONARY ARTERY DISEASE; FEMALE; HOSPITAL MORTALITY; HUMANS; INFANT; MALE; MIDDLE AGED; NATIONAL HEALTH PROGRAMS; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); SEX DISTRIBUTION; TREATMENT OUTCOME;

EID: 79957888109     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/S0066-782X2011005000035     Document Type: Review

References (31)

1. Gruentzig AR, Myler RK, Hanna ES, Turina MI. Coronary transluminal angioplasty. [Abstract]. Circulation. 1977;56(Suppl. 3):III-84.
2. Sigwart U, Puel J, Mircovitcht V, Joffre F, Kappenberger L. Intravascular stents to prevent occlusion and restenosis after transluminal angioplasty. N Engl J Med. 1987;316(12):701-6.
3. Morice MC, Serruys PW, Sousa JE, Fajadet J, Ban Hayashi E, Perin M, et al. RAVEL Study Group. Randomized Study with the Sirolimus-Coated Bx Velocity Balloon-Expandable Stent in the Treatment of Patients with de Novo Native Coronary Artery Lesions. A randomized comparison of a sirolimuseluting stent with a standard stent for coronary revascularization. Surg Neurol. 2003;59(3):146-7.
4. Grube E, Silber S, Hauptmann KE, Mueller R, Buellesfeld L, Gerckens U, et al. TAXUS I: six-and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions. N Engl J Med. 2008;358(4):405-7.
5. Kedhi E, Joesoef KS, McFadden E, Wassing J, Van Mieghem C, Goedhart D, et al. Second-generation everolimus-eluting and paclitaxel-eluting stents in reallife practice (COMPARE): a randomized trial. Lancet. 2010;375(9710):201-9.
6. Semiys PW, Silber S, Garg S, Van Geuns RJ, Richardt G, Buszman PA, et al. Comparison of zotarolimus-eluting and everolimus-eluting coronary stents. N Engl J Med. 2010;363(2):136-46.
7. Ministério da Saúde. DATASUS. (Departamento de Informática do SUS). [Acesso em 2010 abr 10]. Disponível em http://www2.datasus.gov.br/ DATASUS/index.php
8. Ministério da Saúde. Agencia Nacional de Saúde Suplementar. Informação em saúde suplementar. [Acesso em 2010 abr 10]. Disponível em http://www. ans.gov.br
9. Movahed MR, Ramaraj R, Jamal MM, Hashemzadeh M. Nationwide trends in the utilization of multivessel percutaneous coronary intervention (MVPCI) in the United States across different gender and ethniticities. J Interv Cardiol. 2009;22(3):247-51.
10. Movahed MR, Hashemzadeh M, Jammal MM, Ramaraj R. Decreasing inhospital mortality of patients undergoing percutaneous coronary intervention with persistent higher mortality rates in women and minorities in the United States. J Invasive Cardiol. 2010;22(2):58-60.
11. Piegas LS, Bittar OJNV, Haddad N. Cirurgia de revascularização miocárdica: resultados do Sistema Único de Saúde. Arq Bras Cardiol. 2009;93(5):555-60.
12. Ministério da Saúde. Indicadores e dados básicos-Brasil-2008. Rede interagencial de informações para a saúde. [Acesso em 2010 abr 10]. Disponível em http://tabnet.datasus.gov.br
13. Ministério da Saúde. Agencia Nacional de Saúde Suplementar. ANS lança norma de fiscalização pró-ativa: dados gerais. [Acesso em 2010 mar 15]. Disponível em http://www.ans.gov.br
14. National Services Scotland. Public Health Information for Scotland. Coronary heart disease statistics. [Access on 2010 Mar 15]. Available from http://www. isdscotland.org/isd/6060.html
15. British Cardiovascular Intervention Society. [Access on 2010 May 8]. Available from http://www.bcis.org.uk/pages/default.asp
16. Canadian Institute for Health Information. Health System Characteristics. Percutaneous Coronary Intervention Rate. [Access on 2010 Feb 20]. Available from http://secure.cihi.ca/cihiweb/
17. Canadian Institute for Health Information. Indicator Reports 2008. [Access on 2010 Mar 15]. Available from http://secure.cihi.ca/hireports/
18. American Heart Association. Heart disease & stroke statistics. 2010 Update. (At-A-Glance Version). [Access on 2010 Mar 15]. Available from http://www. americanheart.org/presenter.jhtm?identifier=120026
19. Hannan EL, Wu C, Walford G, King SB 3rd, Holmes DR Jr, Ambrose JA, et al. Volume-outcome relationships for percutaneous coronary interventions in the stent era. Circulation. 2005;112(8):1171-9.
20. Godoy PH, Klein CH, Souza-e-Silva N, Oliveira GM. Hospital case fatality associated with coronary angioplasty in Rio de Janeiro State, Brazil, 1999-2003. Cad Saúde Pública. 2007;23(4):845-51.
21. Peterson ED, Dai D, DeLong ER, Brennan JM, Singh M, Rao SV, et al. NCDR Registry Participants. Contemporary mortality risk prediction for percutaneous coronary intervention: results from 588,398 procedures in the National Cardiovascular Data Registry. J Am Coll Cardiol. 2010;55(18):1923-32.
22. Luft HS, Bunker JP, Enthoven AC. Should operations be regionalized? The empirical relation between surgical volume and mortality. N Engl J Med. 1979;301(25):1364-9.
23. Singh M, Rihal CS, Gersh BJ, Roger VL, Bell MR, Lennon RJ, et al. Mortality differences between men and women after percutaneous coronary interventions: a 25-year, single-center experience. J Am Coll Cardiol. 2008;51(24):2313-20.
24. Lansky AJ. Outcomes of percutaneous and surgical revascularization in women. Prog Cardiovasc Dis. 2004;46(4):305-19.
25. Feldman DN, Gade CL, Slotwiner AJ, Parikh M, Bergman G, Wong SC, et al. Comparison of outcomes of percutaneous coronary interventions in patients of three age groups (<60, 60 to 80, and > 80 years) (from the New York State Angioplasty Registry). Am J Cardiol. 2006;98(10):1334-9.
26. Jacobs AK. Coronary intervention in 2009: are women no different than men? Circ Cardiovasc Interv. 2009;2(1):69-78.
27. Jamal SM, Shrive FM, Ghali WA, Knudtson ML, Eisenberg MJ. In-hospital outcomes after percutaneous coronary intervention in Canada:1992/93 to 2000/01. Can J Cardiol. 2003;19(7):782-9.
28. Hamburger JN, Walsh SJ, Khurana R, Ding L, Gao M, Humphries KH, et al. Percutaneous coronary intervention and 30-day mortality. The British Columbia PCI Risk Score. Cathet Cardiovasc Intervent. 2009;74(3):377-85.
29. Sousa AGMR, Sousa JEMR, Costa Junior JR, Abizaid AAC, Buitrón F, Marchant E, et al. Perfil demográfico e resultados imediatos dos pacientes submetidos a angioplastia primária no Registro SOLACI. Rev Bras Cardiol Invas. 2009;17:335-9.
30. Srinivas VS, Hailpern SM, Koss E, Monrad ES, Alderman MH. Effect of physician volume on the relationship between hospital volume and mortality during primary angioplasty. J Am Coll Cardiol. 2009;53(7):574-9.
31. Roe MT, Messenger JC, Weintraub WS, Cannon CP, Fonarow GC, Dai D, et al. Treatments, trends, and outcomes of acute myocardial infarction and percutaneous coronary intervention. J Am Coll Cardiol. 2010;56(4):254-63.